ACUTA CAPITAL PARTNERS, LLC Hedge Fund

Location: Redwood City, CA

CIK: 0001582844 · Show all filings

Period: Q1 2020 (← Previous) (Next →)

Filing Date: May 15, 2020

Total Value: $206M (100.0% shares, 0.0% debt)

Holdings (32)

— AVADEL PHARMACEUTICALS PLC 10.2%

Value $20.95M Shares 2,673,718 Est. Cost $7.66 Unrealized —

AXSM AXSOME THERAPEUTICS INC 8.8%

Value $18.15M Shares 308,500 Est. Cost $23.68 Unrealized +244.1%

— ADVERUM BIOTECHNOLOGIES INC 8.1%

Value $16.65M Shares 1,704,500 Est. Cost $11.13 Unrealized —

IOVA IOVANCE BIOTHERAPEUTICS INC 5.8%

Value $11.96M Shares 399,500 Est. Cost $7.92 Unrealized +234.8%

ARVN ARVINAS INC 5.5%

Value $11.29M Shares 280,120 Est. Cost $19.30 Unrealized +142.4%

AUPH AURINIA PHARMACEUTICALS INC 5.4%

Value $11.17M Shares 770,000 Est. Cost $6.93 Unrealized +154.5%

— BELLUS HEALTH INC NEW 5.2%

Value $10.68M Shares 1,070,000 Est. Cost $7.29 Unrealized —

— KADMON HLDGS INC 4.8%

Value $9.888M Shares 2,360,000 Est. Cost $3.68 Unrealized —

— VERASTEM INC 4.6%

Value $9.496M Shares 3,720,930 Est. Cost $2.55 Unrealized —

XENE XENON PHARMACEUTICALS INC 3.5%

Value $7.127M Shares 628,500 Est. Cost $8.16 Unrealized +74.6%

ASND ASCENDIS PHARMA A S 3.4%

Value $7.117M Shares 63,200 Est. Cost $122.05 Unrealized —

— BIOXCEL THERAPEUTICS INC 3.4%

Value $7.04M Shares 315,000 Est. Cost $22.35 Unrealized —

— CATALYST BIOSCIENCES INC 2.9%

Value $6.051M Shares 1,384,600 Est. Cost $4.37 Unrealized —

— SELECTA BIOSCIENCES INC 2.8%

Value $5.698M Shares 2,364,204 Est. Cost $2.26 Unrealized —

APLS APELLIS PHARMACEUTICALS INC 2.7%

Value $5.613M Shares 209,500 Est. Cost $28.50 Unrealized +24.6%

— LIFESCI ACQUISITION CORP 2.7%

Value $5.599M Shares 560,000 Est. Cost $10.00 Unrealized —

— MERSANA THERAPEUTICS INC 2.3%

Value $4.824M Shares 827,500 Est. Cost $5.83 Unrealized —

— DICERNA PHARMACEUTICALS INC 2.3%

Value $4.712M Shares 256,500 Est. Cost $22.03 Unrealized —

— CONSTELLATION PHARMCETICLS I 2.1%

Value $4.383M Shares 139,464 Est. Cost $47.11 Unrealized —

— KARUNA THERAPEUTICS INC 2.0%

Value $4.032M Shares 56,000 Est. Cost $75.34 Unrealized —

— REATA PHARMACEUTICALS INC 1.6%

Value $3.392M Shares 23,500 Est. Cost $80.29 Unrealized —

— APPLIED THERAPEUTICS INC 1.6%

Value $3.334M Shares 102,000 Est. Cost $18.14 Unrealized —

ARWR ARROWHEAD PHARMACEUTICALS IN 1.5%

Value $3.156M Shares 109,700 Est. Cost $23.72 Unrealized +70.1%

RLMD RELMADA THERAPEUTICS INC 1.5%

Value $3.102M Shares 90,950 Est. Cost $40.32 Unrealized 0.0%

QURE UNIQURE NV 1.2%

Value $2.515M Shares 53,000 Est. Cost $56.25 Unrealized +2.1%

— MARINUS PHARMACEUTICALS INC 1.0%

Value $2.107M Shares 1,038,000 Est. Cost $2.03 Unrealized —

— GLOBAL BLOOD THERAPEUTICS IN 1.0%

Value $1.993M Shares 39,000 Est. Cost $51.10 Unrealized —

KURA KURA ONCOLOGY INC 1.0%

Value $1.97M Shares 198,000 Est. Cost $16.00 Unrealized -28.5%

— ZAFGEN INC 0.5%

Value $1.067M Shares 1,386,000 Est. Cost $1.02 Unrealized —

BCRX BIOCRYST PHARMACEUTICALS 0.2%

Value $500K Shares 250,000 Est. Cost $2.52 Unrealized +9.5%

— IVERIC BIO INC 0.2%

Value $478K Shares 139,000 Est. Cost $8.58 Unrealized —

ABUS ARBUTUS BIOPHARMA CORP 0.1%

Value $273K Shares 269,907 Est. Cost $2.70 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	AVADEL PHARMACEUTICALS PLC	2,673,718	$20.95M	10.2%	$7.66	—	SPONSORED ADR	05337M104
AXSM	AXSOME THERAPEUTICS INC	308,500	$18.15M	8.8%	$23.68	+244.1%	COM	05464T104
—	ADVERUM BIOTECHNOLOGIES INC	1,704,500	$16.65M	8.1%	$11.13	—	COM	00773U108
IOVA	IOVANCE BIOTHERAPEUTICS INC	399,500	$11.96M	5.8%	$7.92	+234.8%	COM	462260100
ARVN	ARVINAS INC	280,120	$11.29M	5.5%	$19.30	+142.4%	COM	04335A105
AUPH	AURINIA PHARMACEUTICALS INC	770,000	$11.17M	5.4%	$6.93	+154.5%	COM	05156V102
—	BELLUS HEALTH INC NEW	1,070,000	$10.68M	5.2%	$7.29	—	COM NEW	07987C204
—	KADMON HLDGS INC	2,360,000	$9.888M	4.8%	$3.68	—	COM	48283N106
—	VERASTEM INC	3,720,930	$9.496M	4.6%	$2.55	—	COM	92337C104
XENE	XENON PHARMACEUTICALS INC	628,500	$7.127M	3.5%	$8.16	+74.6%	COM	98420N105
ASND	ASCENDIS PHARMA A S	63,200	$7.117M	3.4%	$122.05	—	SPONSORED ADR	04351P101
—	BIOXCEL THERAPEUTICS INC	315,000	$7.04M	3.4%	$22.35	—	COM	09075P105
—	CATALYST BIOSCIENCES INC	1,384,600	$6.051M	2.9%	$4.37	—	COM NEW	14888D208
—	SELECTA BIOSCIENCES INC	2,364,204	$5.698M	2.8%	$2.26	—	COM	816212104
APLS	APELLIS PHARMACEUTICALS INC	209,500	$5.613M	2.7%	$28.50	+24.6%	COM	03753U106
—	LIFESCI ACQUISITION CORP	560,000	$5.599M	2.7%	$10.00	—	UNIT 03/31/2025	53228P208
—	MERSANA THERAPEUTICS INC	827,500	$4.824M	2.3%	$5.83	—	COM	59045L106
—	DICERNA PHARMACEUTICALS INC	256,500	$4.712M	2.3%	$22.03	—	COM	253031108
—	CONSTELLATION PHARMCETICLS I	139,464	$4.383M	2.1%	$47.11	—	COM	210373106
—	KARUNA THERAPEUTICS INC	56,000	$4.032M	2.0%	$75.34	—	COM	48576A100
—	REATA PHARMACEUTICALS INC	23,500	$3.392M	1.6%	$80.29	—	CL A	75615P103
—	APPLIED THERAPEUTICS INC	102,000	$3.334M	1.6%	$18.14	—	COM	03828A101
ARWR	ARROWHEAD PHARMACEUTICALS IN	109,700	$3.156M	1.5%	$23.72	+70.1%	COM	04280A100
RLMD	RELMADA THERAPEUTICS INC	90,950	$3.102M	1.5%	$40.32	0.0%	COM	75955J402
QURE	UNIQURE NV	53,000	$2.515M	1.2%	$56.25	+2.1%	SHS	N90064101
—	MARINUS PHARMACEUTICALS INC	1,038,000	$2.107M	1.0%	$2.03	—	COM	56854Q101
—	GLOBAL BLOOD THERAPEUTICS IN	39,000	$1.993M	1.0%	$51.10	—	COM	37890U108
KURA	KURA ONCOLOGY INC	198,000	$1.97M	1.0%	$16.00	-28.5%	COM	50127T109
—	ZAFGEN INC	1,386,000	$1.067M	0.5%	$1.02	—	COM	98885E103
BCRX	BIOCRYST PHARMACEUTICALS	250,000	$500K	0.2%	$2.52	+9.5%	COM	09058V103
—	IVERIC BIO INC	139,000	$478K	0.2%	$8.58	—	COM	46583P102
ABUS	ARBUTUS BIOPHARMA CORP	269,907	$273K	0.1%	$2.70	0.0%	COM	03879J100